Levosimendan is a calcium-sensitizing inodilator indicated for the short-term management of acute decompensated heart failure. By binding to cardiac troponin C, it enhances myocardial contractility without… Read more







![Chemical structure of 2-[2-[4-(2-Azidotetrahydro-3-methyl-5-oxo-2-furanyl)phenyl]hydrazinylidene]propanedinitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F252638-01-0-2-2-4-2-Azidotetrahydro-3-methyl-5-oxo-2-furanylphenylhydrazinylidenepropanedinitrile.png&w=3840&q=75)










































Levosimendan is a calcium-sensitizing inodilator indicated for the short-term management of acute decompensated heart failure. By binding to cardiac troponin C, it enhances myocardial contractility without significantly increasing oxygen consumption, while simultaneously promoting vasodilation through the opening of ATP-sensitive potassium channels. This catalogue category provides a comprehensive range of reference standards, including levosimendan itself, its related pharmaceutical impurities, metabolites, and stable isotope labelled compounds. These high-purity materials are essential for pharmaceutical laboratories to perform accurate impurity profiling, conduct rigorous stability testing, and validate analytical methods such as HPLC-MS/MS. By utilizing these characterized reference standards, researchers and quality control professionals can ensure the precise identification and quantification of degradation products and metabolic intermediates throughout the drug development and manufacturing lifecycle, ultimately supporting the maintenance of high therapeutic safety and efficacy standards.